‹ All stocks

Forte Biosciences

FBRX · NASDAQ · Healthcare

$76.99

▲ $0.02 (0.03%)

1D 7D 1M 3M 1Y All

Day range

$76.96 – $77.00

Year range

$10.30 – $77.20

Open

$76.97

Previous close

$76.97

Market cap

$1.58B

Volume (24h)

$1.4M

Volume (52w)

$107.78M

Performance

— 0.00%

▲ 277.22%

▲ 191.19%

▲ 430.23%

YTD

▲ 226.09%

▲ 397.35%

▲ 4.04%

All-time

▼ -98.35%

Key statistics

P/E ratio

-15.71

EPS (TTM)

$-4.90

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

20.5M

About Forte Biosciences

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1139.65	-1.23%
JNJ Johnson & Johnson	$256.11	-1.42%
ABBV AbbVie	$260.91	0.45%
MRK Merck & Co.	$143.38	-0.27%
UNH UnitedHealth Group Incorp…	$368.09	0.81%